Public anger over the cost of drugs has burned hot for a year, coursing through social media, popping up on the presidential campaign, and erupting in a series of congressional hearings, including one last month over the rising price of the allergy treatment EpiPen. “It is a conflict of interest, because the interests of the pharmaceutical industry,...